nodes	percent_of_prediction	percent_of_DWPC	metapath
Kanamycin—Vestibular toxicity—Cisplatin—peripheral nervous system neoplasm	0.231	0.231	CcSEcCtD
Kanamycin—Ototoxicity—Tretinoin—peripheral nervous system neoplasm	0.0616	0.0616	CcSEcCtD
Kanamycin—Ototoxicity—Isotretinoin—peripheral nervous system neoplasm	0.0616	0.0616	CcSEcCtD
Kanamycin—Ototoxicity—Alitretinoin—peripheral nervous system neoplasm	0.0467	0.0467	CcSEcCtD
Kanamycin—Ototoxicity—Cisplatin—peripheral nervous system neoplasm	0.0398	0.0398	CcSEcCtD
Kanamycin—Nephrotoxicity—Cisplatin—peripheral nervous system neoplasm	0.0251	0.0251	CcSEcCtD
Kanamycin—Neurotoxicity—Vincristine—peripheral nervous system neoplasm	0.0233	0.0233	CcSEcCtD
Kanamycin—Neurotoxicity—Cisplatin—peripheral nervous system neoplasm	0.0206	0.0206	CcSEcCtD
Kanamycin—Neurotoxicity—Etoposide—peripheral nervous system neoplasm	0.0189	0.0189	CcSEcCtD
Kanamycin—Azotaemia—Vincristine—peripheral nervous system neoplasm	0.017	0.017	CcSEcCtD
Kanamycin—Nephropathy toxic—Cisplatin—peripheral nervous system neoplasm	0.0139	0.0139	CcSEcCtD
Kanamycin—Paralysis—Vincristine—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Kanamycin—Hearing impaired—Tretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Kanamycin—Hearing impaired—Isotretinoin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Kanamycin—Nephropathy toxic—Etoposide—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Kanamycin—Nystagmus—Vincristine—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Kanamycin—Neurotoxicity—Epirubicin—peripheral nervous system neoplasm	0.0106	0.0106	CcSEcCtD
Kanamycin—Deafness—Tretinoin—peripheral nervous system neoplasm	0.01	0.01	CcSEcCtD
Kanamycin—Deafness—Isotretinoin—peripheral nervous system neoplasm	0.01	0.01	CcSEcCtD
Kanamycin—Hearing impaired—Alitretinoin—peripheral nervous system neoplasm	0.00985	0.00985	CcSEcCtD
Kanamycin—Neurotoxicity—Doxorubicin—peripheral nervous system neoplasm	0.00979	0.00979	CcSEcCtD
Kanamycin—Apnoea—Etoposide—peripheral nervous system neoplasm	0.00863	0.00863	CcSEcCtD
Kanamycin—Hearing impaired—Cisplatin—peripheral nervous system neoplasm	0.00839	0.00839	CcSEcCtD
Kanamycin—Deafness—Alitretinoin—peripheral nervous system neoplasm	0.00761	0.00761	CcSEcCtD
Kanamycin—Deafness—Vincristine—peripheral nervous system neoplasm	0.00733	0.00733	CcSEcCtD
Kanamycin—Deafness—Cisplatin—peripheral nervous system neoplasm	0.00648	0.00648	CcSEcCtD
Kanamycin—Paralysis—Epirubicin—peripheral nervous system neoplasm	0.0059	0.0059	CcSEcCtD
Kanamycin—Tinnitus—Tretinoin—peripheral nervous system neoplasm	0.00579	0.00579	CcSEcCtD
Kanamycin—Tinnitus—Isotretinoin—peripheral nervous system neoplasm	0.00579	0.00579	CcSEcCtD
Kanamycin—Nystagmus—Epirubicin—peripheral nervous system neoplasm	0.00574	0.00574	CcSEcCtD
Kanamycin—Albuminuria—Epirubicin—peripheral nervous system neoplasm	0.00549	0.00549	CcSEcCtD
Kanamycin—Paralysis—Doxorubicin—peripheral nervous system neoplasm	0.00546	0.00546	CcSEcCtD
Kanamycin—Nystagmus—Doxorubicin—peripheral nervous system neoplasm	0.00531	0.00531	CcSEcCtD
Kanamycin—Albuminuria—Doxorubicin—peripheral nervous system neoplasm	0.00508	0.00508	CcSEcCtD
Kanamycin—Oliguria—Epirubicin—peripheral nervous system neoplasm	0.00445	0.00445	CcSEcCtD
Kanamycin—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Kanamycin—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Kanamycin—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Kanamycin—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Kanamycin—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Kanamycin—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Kanamycin—Pain—Topotecan—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Kanamycin—Pain—Tretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Kanamycin—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Kanamycin—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00374	0.00374	CcSEcCtD
Kanamycin—Pain—Melphalan—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Kanamycin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00355	0.00355	CcSEcCtD
Kanamycin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00352	0.00352	CcSEcCtD
Kanamycin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Kanamycin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Kanamycin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Kanamycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Kanamycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Kanamycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Kanamycin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Kanamycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Kanamycin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Kanamycin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Kanamycin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Kanamycin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Kanamycin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Kanamycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Kanamycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Kanamycin—Rash—Topotecan—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Kanamycin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Kanamycin—Headache—Topotecan—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Kanamycin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Kanamycin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Kanamycin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Kanamycin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Kanamycin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Kanamycin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Kanamycin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Kanamycin—Pain—Vincristine—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Kanamycin—Rash—Melphalan—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Kanamycin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Kanamycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Kanamycin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Kanamycin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Kanamycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Kanamycin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Kanamycin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Kanamycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Kanamycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Kanamycin—Pain—Cisplatin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Kanamycin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Kanamycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Kanamycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Kanamycin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Kanamycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Kanamycin—Pain—Etoposide—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Kanamycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Kanamycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Kanamycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Kanamycin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Kanamycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Kanamycin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Kanamycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Kanamycin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Kanamycin—Rash—Vincristine—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Kanamycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Kanamycin—Headache—Vincristine—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Kanamycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Kanamycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Kanamycin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Kanamycin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Kanamycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Kanamycin—Rash—Cisplatin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Kanamycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Kanamycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Kanamycin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Kanamycin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Kanamycin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Kanamycin—Rash—Etoposide—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Kanamycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Kanamycin—Headache—Etoposide—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Kanamycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Kanamycin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Kanamycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Kanamycin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Kanamycin—Pain—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Kanamycin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Kanamycin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Kanamycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Kanamycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Kanamycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Kanamycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
Kanamycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Kanamycin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000923	0.000923	CcSEcCtD
Kanamycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Kanamycin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000917	0.000917	CcSEcCtD
Kanamycin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000869	0.000869	CcSEcCtD
Kanamycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000861	0.000861	CcSEcCtD
Kanamycin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.000854	CcSEcCtD
Kanamycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Kanamycin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000848	0.000848	CcSEcCtD
Kanamycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000804	CcSEcCtD
